Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06334055 · ClinicalTrials.gov registry record · NA
Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT06334055: Completed NA study, sponsored by Masimo Corporation.
NCT06334055 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06334055, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The aim of the study is to validate the Mean Arterial Pressure (MAP) parameter of Masimo INVSENSOR00073 against the gold standard blood pressure measurements from the arterial line while subject undergo a blood pressure variation procedure.
Primary Outcome
Accuracy and precision of mean arterial pressure (MAP) measured by Masimo INVSENSOR00073 in comparison to radial arterial line.
Interventions
- DEVICE Masimo INVSENSOR00073
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2024-11-08 |
| Phase | NA |
What the finished NCT06334055 record still lists
NCT06334055 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Masimo INVSENSOR00073 is the first listed.
NCT06334055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06334055 about?
NCT06334055 is a clinical study titled "Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073". The aim of the study is to validate the Mean Arterial Pressure (MAP) parameter of Masimo INVSENSOR00073 against the gold standard blood pressure measurements from the arterial line while subject undergo a blood pressure variation procedure.
What is the current status of trial NCT06334055?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2024-03-04. Estimated completion is 2024-11-08.
What interventions are being tested in trial NCT06334055?
The interventions under investigation include: Masimo INVSENSOR00073 (DEVICE).
Who is sponsoring clinical trial NCT06334055?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06334055's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI